Effects of acupuncture on anxiety patients after percutaneous coronary intervention
Objective:To observe effects of acupuncture on anxiety patients after percutaneous coronary intervention (PCI). Methods:A prospective study was conducted on 100 patients with anxiety disorder after PCI who were admitted to the hospital from November 2022 to November 2023. According to the random number table method,they were divided into control group and observation group,50 cases in each group. The control group was treated with Flupentixol and Melitracen,while the study group was treated with acupuncture on the basis of that of the control group. The clinical efficacy,the TCM syndrome score,the anxiety degree[Hamilton anxiety scale (HAMA)]score and the sleep quality[Pittsburgh sleep quality index (PSQI)]score before and after the treatment,and the incidence of adverse reactions were compared between the two groups. Results:The total effective rate of the study group was 94.00％ (47/50),which was higher than 80.00％ (80/50) of the control group,and the difference was statistically significant (P<0.05). After the treatment,the scores of TCM syndromes such as mental depression,chest and hypochondrium distension,and irritability in the two groups were lower than those before the treatment,and those in the study group were lower than the control group,the differences were statistically significant (P<0.05). The HAMA and PSQI scores of the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant (P<0.05). However,there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusions:Acupuncture in the treatment of the patients with anxiety after PCI can improve the clinical efficacy,reduce the TCM syndrome scores,reduce the anxiety,and improve the sleep quality. Moreover,it is superior to simple Flupentixol and Melitracen treatment.
Percutaneous coronary interventionAcupunctureFlupentixol and MelitracenAnxietyTCM syndrome score
万方数据
维普
